STXS

Stereotaxis, Inc. (STXS) ESG Analysis Analysis (2026)

Invetso Score: 6.9/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 6.4 (Moderate)

STXS appears moderately positioned on environmental intensity because its R&D-to-revenue ratio suggests a lower direct operating footprint than manufacturing-heavy peers, though product lifecycle impacts remain relevant.

The company’s capital-light profile likely reduces energy, water, and waste exposure versus industrial medtech peers, but the absence of disclosed emissions metrics limits peer-verifiable strength.

Environmental risk is mainly indirect through supply-chain and product stewardship expectations, which are material in medical devices but typically less burdensome than for heavy manufacturing peers.

Compared with larger diversified healthcare peers, STXS likely faces fewer site-based environmental liabilities, yet its disclosure depth appears insufficient to support a stronger relative score.

Social

Score:

STXS is relatively well positioned socially because high R&D intensity supports innovation in patient care, a material advantage versus peers with less clinically differentiated offerings.

The company’s low debt burden can support workforce stability and continuity, which reduces social execution risk relative to more financially constrained peers.

Stock-based compensation remains elevated versus revenue, indicating retention alignment but also potential dilution-related employee sentiment pressure compared with peers.

As a medical technology company, product safety and clinical outcomes are central social factors, and STXS appears broadly aligned with peer expectations without evident structural controversy.

Governance

Score:

STXS shows mixed governance positioning because modest leverage suggests balance-sheet discipline, but elevated stock-based compensation can weaken alignment versus better-governed peers.

High R&D intensity is consistent with governance support for long-term innovation, yet it also raises oversight demands on capital allocation and project discipline.

The company’s relatively low debt-to-equity ratio reduces creditor pressure and governance fragility compared with more leveraged peers, supporting a steadier control environment.

Limited public evidence on board independence, executive accountability, and shareholder protections constrains confidence, keeping governance below stronger-disclosure peers.

Overall Score

Score:

STXS is moderately positioned overall, with stronger social characteristics offset by limited environmental disclosure and only average governance visibility versus peers.

Score Driver: High R&D Intensity Supports Social Relevance And Innovation, But Disclosure Limitations Prevent A Stronger Relative ESG Assessment.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Stereotaxis, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →